United Therapeutics | Les Charges D'Exploitation



Operating Expenses Changement Date
Amarin USD 67.47M 549K 2024-09
Ardelyx USD 108M 12M 2024-12
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Insmed USD 334.86M 28M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
J&J USD 18.63B 500M 2024-12
Moderna USD 2.21B 280M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Teva Pharmaceutical Industries USD 3.77B 609M 2024-12
United Therapeutics USD 378.2M 27.6M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



United Therapeutics Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.